Prostaglandin H2 structure
|
Common Name | Prostaglandin H2 | ||
|---|---|---|---|---|
| CAS Number | 42935-17-1 | Molecular Weight | 352.465 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 490.1±40.0 °C at 760 mmHg | |
| Molecular Formula | C20H32O5 | Melting Point | 42.8ºC | |
| MSDS | USA | Flash Point | 165.5±20.8 °C | |
| Symbol |
GHS02, GHS07 |
Signal Word | Danger | |
| Name | prostaglandin H2 |
|---|---|
| Synonym | More Synonyms |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 490.1±40.0 °C at 760 mmHg |
| Melting Point | 42.8ºC |
| Molecular Formula | C20H32O5 |
| Molecular Weight | 352.465 |
| Flash Point | 165.5±20.8 °C |
| Exact Mass | 352.224976 |
| PSA | 75.99000 |
| LogP | 3.57 |
| Vapour Pressure | 0.0±2.8 mmHg at 25°C |
| Index of Refraction | 1.546 |
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H302 + H312 + H332-H319 |
| Precautionary Statements | P210-P261-P280-P305 + P351 + P338-P370 + P378-P403 + P235 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | F: Flammable;Xi: Irritant; |
| Risk Phrases | 11-36-66-67 |
| Safety Phrases | 9-16-26 |
| RIDADR | UN 1090 3/PG 2 |
|
~%
Prostaglandin H2 CAS#:42935-17-1 |
| Literature: Salomon; Miller; Zagorski; Coughlin Journal of the American Chemical Society, 1984 , vol. 106, # 20 p. 6049 - 6060 |
|
~%
Prostaglandin H2 CAS#:42935-17-1 |
| Literature: Vanderbilt University Patent: US2005/2859 A1, 2005 ; Location in patent: Page/Page column 6 ; US 20050002859 A1 |
|
What we know about primary dysmenorrhea today: a critical review.
Hum. Reprod. Update 21 , 762-78, (2015) Primary dysmenorrhea, or painful menstruation in the absence of pelvic pathology, is a common, and often debilitating, gynecological condition that affects between 45 and 95% of menstruating women. De... |
|
|
Anti-peptide antibodies against the human blood platelet thromboxane A2/prostaglandin H2 receptor. Production, purification and characterization.
Biochem. Pharmacol. 45(10) , 2071-8, (1993) Two anti-peptide antibodies have been raised against the human blood platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor. Based on the published sequence of the placental TXA2/PGH2 receptor,... |
|
|
Evidence for coordinate, selective regulation of eicosanoid synthesis in platelet-derived growth factor-stimulated 3T3 fibroblasts and in HL-60 cells induced to differentiate into macrophages or neutrophils.
J. Biol. Chem. 263(36) , 19384-91, (1988) We used Swiss 3T3 fibroblasts stimulated with platelet-derived growth factor and HL-60 cells induced to differentiate into macrophages or neutrophils to study the regulation of prostaglandin and leuko... |
| (5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-Hydroxy-1-octen-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}-5-heptenoic acid |
| 5-Heptenoic acid, 7-[(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl]-, (5Z)- |
| Endoperoxide H2 PGH2 Prostaglandin R2 |
| Prostaglandin H2 |
| MFCD00036972 |